FDA Clearance Tracker · P150005-S001
BLAZER OPEN-IRRIGATED ABLATION CATHETER
Last checked: Nov 20, 2026Latest source record: Jul 5, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jul 5, 2016
Approved
Time to decision
126 days
Received Mar 1, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150005-S001
- Device name
- BLAZER OPEN-IRRIGATED ABLATION CATHETER
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- Mar 1, 2016
- Decided
- Jul 5, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150005
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its evaluation of your premarket approval application (PMA) supplement, which requested approval for a manufacturing site located at Boston Scientific Corporation, 302 Parkway, Global Park, Heredia, Costa Rica, to manufacture the Blazer Open-Irrigated Ablation Catheter.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.